Galaxy Digital Inc. Class A Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.84 (market cap $3.90B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.51B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.7× Galaxy Digital Inc. Class A Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Galaxy Digital Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| GLXY | IBRX | |
|---|---|---|
Market Cap | $3.90B | $10.51B |
Volume | 7,887,173 | 10,445,785 |
Sector | Financials | Health |
52-Week High | $42.86 | $11.55 |
52-Week Low | $16.84 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.36B | $10.97B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.
Read more on GLXY →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →